Thomas Marron
Clinical trials sponsored by Thomas Marron, explained in plain language.
-
New drug cocktail aims to Re-Spark immune system against stubborn lung cancer
Disease control OngoingThis trial is testing the safety and effectiveness of adding two drugs, dupilumab and anakinra, to standard immunotherapy for people with advanced non-small cell lung cancer that has returned or stopped responding to prior treatment. The goal is to see if this three-drug combinat…
Phase: PHASE1, PHASE2 • Sponsor: Thomas Marron • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Old HIV drug gets new shot at fighting stubborn cancers
Disease control OngoingThis early-stage trial is testing whether adding lamivudine, a drug typically used for HIV, can help restart the effectiveness of immunotherapy in patients with advanced solid tumors that have stopped responding. The study will enroll 6-24 patients at Mount Sinai to first check s…
Phase: PHASE1, PHASE2 • Sponsor: Thomas Marron • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC